Back to top

Can the Rally in Keryx Biopharmaceuticals (KERX) Shares Continue?
October 18, 2013

Read MoreHide Full Article
Keryx Biopharmaceuticals (KERX - Free Report) been on the move lately as the stock has risen by 5.96% in the past four weeks, and it is currently trading well above its 20-Day SMA. This is a pretty solid move higher, but the question that has to be on investors’ minds right now is; can this trend continue?

While there can be no telling for sure, it is certainly encouraging that earnings estimates have risen in the past few weeks on the company, suggesting that sentiment on KERX is moving in the right direction. In fact, the stock currently has a Zacks Rank #2 (Buy), suggesting that the recent run could certainly continue for this in-focus company.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Keryx Biopharmaceuticals, Inc. (KERX) - free report >>

More from Zacks Tale of the Tape

You May Like